FDA cosmetics division combination with CDER a possible scenario, Friedman suggests.
This article was originally published in The Rose Sheet
Executive Summary
FDA COSMETICS DIVISION COMBINATION WITH CDER COULD BE POSSIBLE as one of many scenarios for making better use of narrower agency resources by combining employees from the Office of Cosmetics & Colors with "people with similar sorts of skills" in the Center for Drug Evaluation & Research, Lead Deputy Commissioner Michael Friedman, MD, suggested to a CDER seminar on FDA reform Nov. 5. Friedman made his remarks in response to a question concerning the future of offices or divisions at FDA "that don't have clearly defined regulatory powers such as cosmetics...but have increasing impact on the consumer."